Tag Archives: Merck

Big Keytruda survival win sets Merck up to steal Bristol-Myers Squibb's kidney cancer share

Bristol-Myers Squibb investors have been dreading positive kidney cancer results from archrival Merck for months. And now that they’re here, they might do even more damage to Bristol-Myers’ market share than some industry watchers expected. Results released late Monday in an abstract show that Merck’s immuno-oncology star Keytruda, in tandem with Pfizer’s Inlya, slashed the risk… Read More »

Supreme Court rebuffs appeals from Merck, Gilead in 2 high-profile drug battles

Monday was a good-news-bad-news day for Gilead Sciences at the U.S. Supreme Court, with the justices handing down multiple decisions about which appeals they would take up as they headed back to work after the holiday break. SCOTUS refused to hear Gilead’s appeal in a whistleblower case alleging it lied to the FDA about unapproved… Read More »